Agilent Technologies Inc (A)
140.47
+0.82
(+0.59%)
USD |
NYSE |
Nov 05, 16:00
140.47
0.00 (0.00%)
After-Hours: 19:06
Agilent Technologies Research and Development Expense (Annual): 481.00M for Oct. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| October 31, 2023 | 481.00M |
| October 31, 2022 | 467.00M |
| October 31, 2021 | 441.00M |
| October 31, 2020 | 495.00M |
| October 31, 2019 | 404.00M |
| October 31, 2018 | 387.00M |
| October 31, 2017 | 341.00M |
| October 31, 2016 | 329.00M |
| October 31, 2015 | 330.00M |
| October 31, 2014 | 358.00M |
| October 31, 2013 | 337.00M |
| October 31, 2012 | 668.00M |
| October 31, 2011 | 649.00M |
| Date | Value |
|---|---|
| October 31, 2010 | 612.00M |
| October 31, 2009 | 642.00M |
| October 31, 2008 | 704.00M |
| October 31, 2007 | 685.00M |
| October 31, 2006 | 655.00M |
| October 31, 2005 | 650.00M |
| October 31, 2004 | 599.00M |
| October 31, 2003 | 771.00M |
| October 31, 2002 | 1.169B |
| October 31, 2001 | 1.28B |
| October 31, 2000 | 1.065B |
| October 31, 1999 | 879.00M |
| October 31, 1998 | 948.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
441.00M
Minimum
2021
495.00M
Maximum
2020
471.00M
Average
474.00M
Median
Research and Development Expense (Annual) Benchmarks
| Bio-Rad Laboratories Inc | 247.43M |
| Bruker Corp | 294.80M |
| Azenta Inc | 33.96M |
| Harvard Bioscience Inc | 11.76M |
| Bionano Genomics Inc | 54.03M |